Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell?

It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine ...

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...

National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid ...